Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 14.02.2024
Multitude SE
With full speed into 2024
After two years of delivering significant EBIT growth, we expect Multitude
to continue on its growth path and remain on track to meet the new guidance
for FY26 of € 30m net income. Here is why:
Demand for loans to remain undebatable high. According to a survey of EY,
consumer loans and corporate loans in the Eur [ … ]
Mon, 12.02.2024
Knaus Tabbert AG
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG
(ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 86,00.
Zusammenfassung:
Wir bewerten Knaus Tabbert mit einer Kaufempfehlung und einem Kursziel von
€86. Unserer Ansicht nach hat [ … ]
Fri, 09.02.2024
ad pepper media International N.V.
First Berlin Equity Research hat ein Research Update zu ad pepper media
International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten
von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von
EUR 3,00 auf EUR 2,80.
Zusammenfassung:
ad pepper media (APM) hat vorläufige Zahlen für 2023 vorgelegt, d [ … ]
Fri, 09.02.2024
UBM Development AG
Off to a good start / Muted Q4’23 expected; chg
Yesterday, UBM announced to have received the building permit for the
Timber Peak project in Mainz. Once completed, the 12-storey-building will
exceed a height of 40 metres and will have c. 9,500 sqm gross floor area.
The building will be equipped with heat pumps, heating and cooling panels, [ … ]
Fri, 09.02.2024
SMARTBROKER Holding AG
Another difficult year ahead; chg
For the first time, Smartbroker Holding (SBH) reported monthly trading
stats which can be seen as starting point of the future of the Smartbroker.
Further, the longstanding Group CFO Roland Nicklaus will leave the company
in April. In detail:
The number of customers declined to 175k (-3% mom, excluding 79k de [ … ]
Fri, 09.02.2024
Netfonds AG
Favorable trends to materialize in 2024
Netfonds should strongly benefit from several favorable macroeconomic and
structural trends in 2024:
Strong dollar and equity capital markets close to all-time highs. With c. €
23.2bn AuC in FY23e (eNuW), Netfonds topline is obviously correlated to the
overall capital markets development. The recen [ … ]
Thu, 08.02.2024
Singulus Technologies AG
Positive outlook after a challenging 2023
Topic: Singulus looks back at a difficult FY23 due to project postponements
and cyclical weakness. Nevertheless, there is sun behind the clouds and
FY24e looks more promising.
During the first 9M of FY23, the Solar segment showed weakness in order
intake due to postponements of larger projects. Howeve [ … ]
Wed, 07.02.2024
SFC Energy AG
First Berlin Equity Research hat ein Research Update zu SFC Energy AG
(ISIN: DE0007568578) veröffentlicht. Analyst Dr. Karsten von Blumenthal
bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 34,00.
Zusammenfassung:
SFC Energy hat vorläufige Rekordzahlen vorgelegt, die die Guidance für 2023
und unsere P [ … ]
Tue, 06.02.2024
Sernova Corp
First Berlin Equity Research has published a research update on Sernova
Corp. (ISIN: CA81732W1041). Analyst Christian Orquera reiterated his BUY
rating and maintained his CAD 3.80 price target.
Abstract:
Sernova has published FY 22/23 financial statements and provided a business
update. The figures were roughly as expected. The company reported [ … ]
Tue, 06.02.2024
Ikonisys SA
Creating a leading player in cancer diagnostics
Only weeks after Ikonisys entered a strategic partnership with Biocare
Medical, the company made the next strategic step in business development
by announcing the takeover of Hospitex, an Italian-based cytology company
specialising in oncological diagnostics. According to the company, Hospite [ … ]
